Clinical Trial Update: Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates the combination of ipilimumab and nivolumab in patients with recurrent extensive-stage small cell lung cancer following platinum-ba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Yale University | Conditions: Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING